TLR4 and acute respiratory distress syndrome: Innate immune receptor activation or inactivation has not been studied extensively for severe COVID-19-associated ARDS, but consistent evidence exists for the activation of TLR4 [76,77], TLR7 [78] and NLRP3 [79,80,81].